CTCBIO Inc. (KOSDAQ: A060590)
Health Care · Pharmaceuticals · KR
₩3,040.00
-1.62% today · -47.2% 1Y
CTCBIO Inc. (KOSDAQ: A060590) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $54.06M.
Over the last twelve months the share price has lost 47.2%, trading between 2.57K and 5.97K.
Tweenvest scores CTCBIO Inc. across four factors: quality 70/100, value 59/100. Its strongest factor is quality.
A060590 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $54.06M
- Revenue (TTM)
- $84.94M
- P/E
- 9.61
- EPS
- 313.54
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- ₩5,970.00
- 52-week low
- ₩2,570.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.91M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| K Pharma,Inc.TSE: 4896 | $55.27M | ¥753.00 | +0.40% |
| Sinil Pharmaceutical Co., Ltd.KOSDAQ: A012790 | $55.09M | ₩6,510.00 | +0.46% |
| Chi Sheng Pharma & Biotech Co., LtdTPEX: 4111 | $54.27M | NT$29.00 | +1.05% |
| LeonaBio, Inc.NasdaqCM: LONA | $54.17M | $6.14 | +6.78% |
| Wai Yuen Tong Medicine Holdings LimitedSEHK: 897 | $53.96M | HK$0.38 | +1.33% |
| Navana Pharmaceuticals PLCDSE: NAVANAPHAR | $53.46M | Tk61.30 | -3.46% |
| Citi Pharma LimitedKASE: CPHL | $53.43M | PKRs64.76 | -9.88% |
| Moberg Pharma AB (publ)OM: MOB | $53.32M | Skr11.50 | +1.77% |
Figures last refreshed Oct 11, 2026.